Chiara Riganti Selected Research

Metallocenes

6/2022

Electronic Coupling in 1,2,3-Triazole Bridged Ferrocenes and Its Impact on Reactive Oxygen Species Generation and Deleterious Activity in Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chiara Riganti Research Topics

Disease

110	Neoplasms (Cancer) 11/2022 - 12/2002
14	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2011
14	Colonic Neoplasms (Colon Cancer) 03/2015 - 01/2005
13	Malignant Mesothelioma 03/2022 - 06/2004
11	Hypoxia (Hypoxemia) 12/2021 - 11/2009
11	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 11/2013
10	Osteosarcoma (Osteogenic Sarcoma) 11/2021 - 12/2010
7	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 01/2017
6	Mesothelioma 08/2022 - 06/2004
5	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2019
4	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2010
4	Triple Negative Breast Neoplasms 01/2022 - 10/2018
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2021 - 10/2012
4	Cardiotoxicity 01/2019 - 12/2002
3	Adenocarcinoma 03/2022 - 01/2017
3	Glioma (Gliomas) 03/2017 - 07/2014
2	Colorectal Neoplasms (Colorectal Cancer) 02/2022 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2020
2	Disease Progression 05/2021 - 05/2021
2	Carcinogenesis 03/2021 - 12/2010
2	Phototoxic Dermatitis (Phototoxicity) 01/2021 - 01/2018
2	Adenocarcinoma of Lung 01/2021 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2020
2	Melanoma (Melanoma, Malignant) 12/2020 - 01/2020
2	Neuroblastoma 04/2020 - 01/2020
2	Multiple Myeloma 01/2020 - 10/2019
2	Reperfusion Injury 01/2019 - 03/2015
2	Ischemia 01/2019 - 03/2015
2	Necrosis 01/2019 - 01/2018
2	Inflammation (Inflammations) 01/2019 - 11/2017

Drug/Important Bio-Agent (IBA)

44	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 12/2002
40	Pharmaceutical PreparationsIBA 01/2022 - 09/2003
26	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022 - 11/2009
22	Proteins (Proteins, Gene)FDA Link 08/2022 - 03/2009
11	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2018 - 09/2003
9	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2022 - 02/2016
8	AsbestosIBA 03/2022 - 06/2004
8	EnzymesIBA 02/2022 - 11/2009
8	Zoledronic Acid (Zometa)FDA Link 01/2022 - 12/2010
8	Biological ProductsIBA 01/2022 - 09/2003
8	Mevalonic Acid (Mevalonate)IBA 12/2020 - 12/2010
7	LipidsIBA 01/2022 - 12/2017
7	AntioxidantsIBA 03/2021 - 09/2011
7	Liposomes (Liposome)IBA 12/2020 - 06/2011
7	AnthracyclinesIBA 02/2019 - 12/2002
6	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2020
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 07/2006
6	CholesterolIBA 01/2022 - 01/2011
6	Transcription Factors (Transcription Factor)IBA 03/2021 - 06/2007
6	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2021 - 07/2013
5	LigandsIBA 03/2022 - 10/2012
5	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 07/2005
5	Lipid NanoparticlesIBA 11/2021 - 07/2014
5	multidrug resistance-associated protein 1IBA 05/2020 - 10/2011
5	NF-kappa B (NF-kB)IBA 01/2020 - 09/2003
5	Phosphotransferases (Kinase)IBA 01/2020 - 03/2009
5	carbonic anhydrase XIIIBA 01/2019 - 03/2015
5	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 11/2013
4	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 12/2020
4	ThiosemicarbazonesIBA 03/2022 - 01/2018
4	Small Interfering RNA (siRNA)IBA 02/2022 - 08/2008
4	Nitric Oxide Synthase (NO Synthase)IBA 11/2009 - 06/2004
3	MicroRNAs (MicroRNA)IBA 08/2022 - 03/2022
3	Glutamine (L-Glutamine)FDA Link 03/2022 - 11/2017
3	Heme (Haem)IBA 02/2022 - 01/2021
3	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 01/2018
3	Gemcitabine FDA Link 12/2021 - 12/2020
3	CytokinesIBA 03/2021 - 09/2003
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2020 - 11/2013
3	Protein Isoforms (Isoforms)IBA 01/2020 - 06/2007
3	Adenosine Triphosphate (ATP)IBA 01/2019 - 10/2013
3	liposomal doxorubicin (Doxil)FDA Link 09/2014 - 01/2011
3	Crocidolite Asbestos (Blue Asbestos)IBA 09/2011 - 06/2004
2	IntegrinsIBA 11/2022 - 01/2017
2	Pemetrexed (MTA)FDA Link 08/2022 - 02/2022
2	Thymidylate SynthaseIBA 08/2022 - 08/2022
2	Vitamin D FDA LinkGeneric 01/2022 - 01/2020
2	sigma-2 receptorIBA 12/2021 - 01/2017
2	Oxygen (Dioxygen)IBA 12/2021 - 12/2002
2	MetalsIBA 12/2021 - 01/2018
2	SolutionsIBA 12/2021 - 01/2021
2	Amino Acids FDA Link 12/2021 - 12/2020
2	Hypoxia-Inducible Factor 1IBA 06/2021 - 01/2020
2	PlatinumIBA 05/2021 - 01/2021
2	1,2,5-oxadiazole 2-oxideIBA 01/2021 - 07/2011
2	ProdrugsIBA 01/2021 - 03/2017
2	Terpenes (Terpenoids)IBA 12/2020 - 01/2015
2	EstersIBA 01/2020 - 03/2017
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2020
2	tariquidar (XR9576)IBA 01/2020 - 12/2016
2	Sirtuin 3IBA 01/2020 - 10/2019
2	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 11/2013
2	indolepropanol phosphate (IPP)IBA 01/2020 - 01/2018
2	Chloroquine (Aralen)FDA LinkGeneric 11/2018 - 01/2018
2	CalreticulinIBA 11/2018 - 01/2018

Therapy/Procedure

33	Therapeutics 03/2022 - 06/2008
30	Drug Therapy (Chemotherapy) 08/2022 - 03/2009
5	Immunotherapy 12/2021 - 07/2012
2	Radiotherapy 12/2021 - 12/2017
2	Oral Administration 10/2019 - 11/2011